Literature DB >> 17994550

Is splenectomy still the gold standard for the treatment of chronic ITP?

Francesco Rodeghiero, Marco Ruggeri.   

Abstract

Mesh：

Year:  2008        PMID： 17994550     DOI： 10.1002/ajh.21109

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

Review 1.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

2.  Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.

Authors:  Zhenyu Li; Weiwei Mou; Guang Lu; Jiang Cao; Xupeng He; Xiuying Pan; Kailin Xu
Journal:  Int J Hematol       Date:  2010-12-29       Impact factor: 2.490

Review 3.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

4.  Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy.

Authors:  Karen K W Wang; Cathy Charles; Nancy M Heddle; Emmy Arnold; Laura Molnar; Donald M Arnold
Journal:  Health Expect       Date:  2012-08-07       Impact factor: 3.377

5.  Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.

Authors:  James B Bussel; Christina S Lee; Caroline Seery; Allison A Imahiyerobo; Michaela V Thompson; Diane Catellier; Ithamar G Turenne; Vivek L Patel; Paul A Basciano; Rebecca L Elstrom; Waleed Ghanima
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

6.  Dapsone therapy for refractory immune thrombocytopenia patients: a case series.

Authors:  Ji Yun Lee; Jeong-Ok Lee; Joo Young Jung; Soo-Mee Bang
Journal:  Blood Res       Date:  2017-06-22

Review 7.  Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.

Authors:  Adam Cuker
Journal:  Am J Hematol       Date:  2018-04-15       Impact factor: 10.047

Review 8.  Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.

Authors:  Jose Perdomo
Journal:  Immunotargets Ther       Date:  2016-02-22

9.  Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study.

Authors:  Yimei Feng; Yunshuo Xiao; Hongju Yan; Ping Wang; Wen Zhu; Kaniel Cassady; Zhongmin Zou; Kaifa Wang; Ting Chen; Yao Quan; Zheng Wang; Shijie Yang; Rui Wang; Xiaoping Li; Lei Gao; Cheng Zhang; Yao Liu; Peiyan Kong; Li Gao; Xi Zhang
Journal:  Front Med (Lausanne)       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.